Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Acadia Pharmaceuticals (ACAD) Q3 2014 Earnings
ACAD
+0.86%
5
Aug
Confirmed
Q4 2013
Q1 2014
Q2 2014
Q3 2014
-0.22
-0.19
-0.15
-0.12
Details
Expected EPS
-0.19
Actual EPS
-0.22
Surprise EPS
-0.03
Surprise Percent
+15.79%
Description
Acadia Pharmaceuticals (ACAD) has reported earnings of -0.22 per share for Q3 2014.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login